Variety of treatments to choose from…,”90% of drugs don’t do anythingvast majority target kinases (ser/thr)problematic: never going to be able to achieve tumor specificity that you wanttypically much more specific
but operating at first step of the pathwaymost steadily going to be resistant b/c of mutations that occur downstream from it”